Position in TARS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,810,401
+$6,672,372 QoQ
Shares Held
139,981
+359.3% QoQ
Ownership
0.319%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. TARS ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in TARS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,810,401 | 139,981 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $2,138,029 | 30,478 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $4,638,171 | 56,646 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $4,587,398 | 77,190 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $5,696,108 | 140,610 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $1,436,972 | 27,973 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,152,917 | 129,184 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,477,091 | 440,167 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $546,588 | 20,110 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $1,938,871 | 53,339 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $517,792 | 25,570 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $392,752 | 22,102 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $346,925 | 19,199 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $188,160 | 14,969 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $165,027 | 11,351 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $171,919 | 10,042 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $141,517 | 9,693 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $66,506 | 3,954 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,931,559 | 174,736 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $69,757 | 3,237 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $149,594 | 5,162 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $351,693 | 10,912 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $693,641 | 16,783 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||